Results of a Model Analysis of the Cost-Effectiveness of Liraglutide Versus Exenatide Added to Metformin, Glimepiride, or Both for the Treatment of Type 2 Diabetes in the United StatesWON CHAN LEE; CONNER, Christopher; HAMMER, Mette et al.Clinical therapeutics. 2010, Vol 32, Num 10, pp 1756-1767, issn 0149-2918, 12 p.Article

The Intersection of Safety and Adherence: New Incretin-Based Therapies in Patients with Type 2 Diabetes MellitusZAROWITZ, Barbara J; CONNER, Christopher.Pharmacotherapy. 2009, Vol 29, Num 12, issn 0277-0008, 55S-67S, 2Article

Secondary Failure of Metformin Monotherapy in Clinical PracticeBROWN, Jonathan B; CONNER, Christopher; NICHOLS, Gregory A et al.Diabetes care. 2010, Vol 33, Num 3, pp 501-506, issn 0149-5992, 6 p.Article

A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic OutcomesASCHE, Carl; LAFLEUR, Joanne; CONNER, Christopher et al.Clinical therapeutics. 2011, Vol 33, Num 1, pp 74-109, issn 0149-2918, 36 p.Article

Alzheimer's disease : Clinical features, pathogenesis, and treatmentRATHMANN, Kaye L; CONNER, Christopher S.The Annals of pharmacotherapy. 2007, Vol 41, Num 9, pp 1499-1504, issn 1060-0280, 6 p.Article

Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 DiabetesJOHNSTON, Stephen S; CONNER, Christopher; AAGREN, Mark et al.Diabetes care. 2011, Vol 34, Num 5, pp 1164-1170, issn 0149-5992, 7 p.Article

Effects of experimental forest management on a terrestrial, woodland salamander in MissouriHOCKING, Daniel J; CONNETTE, Grant M; CONNER, Christopher A et al.Forest ecology and management. 2013, Vol 287, pp 32-39, issn 0378-1127, 8 p.Article